1 |
LIM G, TANG A, NG C H, et al. An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD[J]. Clin Gastroenterol Hepatol, 2023,21(3): 619-629.
|
2 |
YOUNOSSI Z M, GOLABI P, PAIK J M, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review[J]. Hepatology, 2023,77(4): 1335-1347.
|
3 |
WIERING L, TACKE F. Treating inflammation to combat non-alcoholic fatty liver disease[J]. J Endocrinol, 2023,256(1):e220194.
|
4 |
HEIDA A, GRUBEN N, CATRYSSE L, et al. The hepatocyte IKK:NF-kappaB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis[J]. Mol Metab, 2021,54: 101349.
|
5 |
JOSHI-BARVE S, BARVE S S, AMANCHERLA K, et al. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes[J]. Hepatology, 2007,46(3): 823-830.
|
6 |
TIAN-QI C, YAN-FANG D, YAN-YAN W, et al. Butyrolactone I attenuates inflammation in murine NASH by inhibiting the NF-kappaB signaling pathway[J]. Biochem Biophys Res Commun, 2022,626: 167-174.
|
7 |
YE L, ZHAO D, XU Y, et al. LncRNA-Gm9795 promotes inflammation in non-alcoholic steatohepatitis via NF-[Formula: see text]B/JNK pathway by endoplasmic reticulum stress[J]. J Transl Med, 2021,19(1): 101.
|
8 |
NADHAN R, ISIDORO C, SONG Y S, et al. Signaling by LncRNAs: Structure, Cellular Homeostasis, and Disease Pathology[J]. Cells, 2022,11(16):2517.
|
9 |
NUNEZ-MARTINEZ H N, RECILLAS-TARGA F. Emerging Functions of lncRNA Loci beyond the Transcript Itself[J]. Int J Mol Sci, 2022,23(11):6258.
|
10 |
STATELLO L, GUO C J, CHEN L L, et al. Gene regulation by long non-coding RNAs and its biological functions[J]. Nat Rev Mol Cell Biol, 2021,22(2): 96-118.
|
11 |
GOYAL B, YADAV S, AWASTHEE N, et al. Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer[J]. Biochim Biophys Acta Rev Cancer, 2021,1875(2): 188502.
|
12 |
王妍茜, 康海军, 周娟, 等. LncRNA NALT通过调控Notch信号通路对H2O2诱导的人晶状体上皮细胞损伤的影响[J]. 实用医学杂志, 2023,39(2): 217-223.
|
13 |
PAN Y, WANG T, ZHAO Z, et al. Novel Insights into the Emerging Role of Neat1 and Its Effects Downstream in the Regulation of Inflammation[J]. J Inflamm Res, 2022,15: 557-571.
|
14 |
WANG S M, LIU G Q, XIAN H B, et al. LncRNA NEAT1 alleviates sepsis-induced myocardial injury by regulating the TLR2/NF-kappaB signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2019,23(11): 4898-4907.
|
15 |
BADMUS O O, HILLHOUSE S A, ANDERSON C D, et al. Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways[J]. Clin Sci (Lond), 2022,136(18): 1347-1366.
|
16 |
苏会吉, 颜耿杰, 彭子明, 等. 氧化应激及炎症因子在代谢相关脂肪性肝病中的作用机制研究进展[J]. 广西医学, 2023,45(6): 718-721.
|
17 |
BU F T, WANG A, ZHU Y, et al. LncRNA NEAT1: Shedding light on mechanisms and opportunities in liver diseases[J]. Liver Int, 2020,40(11): 2612-2626.
|
18 |
VERGANI L. Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis[J]. Curr Med Chem, 2019,26(19): 3439-3456.
|
19 |
范明娟, 聂玉强, 詹琪, 等. 利拉鲁肽联合锌alpha2糖蛋白对棕榈酸诱导的HepG2细胞凋亡、脂质代谢和炎症因子表达的影响[J]. 实用医学杂志, 2021,37(22): 2856-2861.
|
20 |
周俪珊,鄢素琪,熊小雨,等. 补骨脂素和异补骨脂素下调NF-κB活性改善LO2细胞脂代谢紊乱的机制研究[J]. 中国中药杂志, 2019,44(10): 2118-2123.
|
21 |
YU H, LIN L, ZHANG Z, et al. Targeting NF-kappaB pathway for the therapy of diseases: mechanism and clinical study[J]. Signal Transduct Target Ther, 2020,5(1): 209.
|
22 |
LIU W Q, WANG Y J, ZHENG Y, et al. Effects of long non-coding RNA NEAT1 on sepsis-induced brain injury in mice via NF-kappaB[J]. Eur Rev Med Pharmacol Sci, 2019,23(9): 3933-3939.
|
23 |
NONG W. Long non-coding RNA NEAT1/miR-193a-3p regulates LPS-induced apoptosis and inflammatory injury in WI-38 cells through TLR4/NF-kappaB signaling[J]. Am J Transl Res, 2019,11(9): 5944-5955.
|
24 |
崔勤涛, 王学惠, 刘永强, 等. 下调lncRNA Neat1表达通过减少NF-κB P65的细胞核转位保护大鼠心肌缺血再灌注损伤[J]. 中国免疫学杂志, 2022,38(20): 2455-2460.
|